Antiplatelet agents - Open Access .click

Results 11 to 20 of about 3,814,825 (281)

Journal of the Arab Society for Medical Research, 2023
Platelets play a major role in normal hemostatic and thrombotic processes. Aggregation of platelets presents the key pathophysiological step in the development of cardiovascular diseases; hence, antiplatelet agents remain crucial in the treatment of ...
Asma Haffouz, Ali Gargouri, Basma Hadjkacem +2 more
doaj +2 more sources

Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents

Journal of Enzyme Inhibition and Medicinal Chemistry, 2018
Despite the substantial clinical success of aspirin and clopidogrel in secondary prevention of ischemic stroke, up to 40% of patients remain resistant to the available antiplatelet treatment.
Monika Marcinkowska +12 more
doaj +2 more sources

Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet Agents [PDF]

Circulation Research, 2023
Junchao Xu, Michael J Mitchell, Guangjun Nie +2 more
exaly +2 more sources

Editorial: Antiplatelet Agents in Stroke Prevention [PDF]

Frontiers in Neurology, 2021
Gergely Feher +5 more
doaj +2 more sources

Antiplatelet therapy in stroke prevention after non-cardioembolic transient ischemic attack

Неврология, нейропсихиатрия, психосоматика, 2021
The review shows modern concepts on the role of antiplatelet therapy in the secondary prevention of cardiovascular diseases in patients after non-cardioembolic ischemic stroke or transient ischemic attack (TIA). We present an analytical characteristic of
A. V. Fonyakin, L. A. Geraskina, M. Yu. Maksimova +2 more
doaj +1 more source

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease

Frontiers in Neurology, 2021
Background: The use of antiplatelet agents in ischemic moyamoya disease (MMD) is controversial. This study aimed to investigate the effectiveness and safety of antiplatelet therapy compared with conservative treatment and surgical revascularization in ...
Fei Ye +12 more
semanticscholar +1 more source

Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Although antiplatelet agents are frequently prescribed in moyamoya disease in routine clinical practice, there are no large‐scale epidemiologic trials or randomized trial evidence to support their use in patients with moyamoya disease. Methods
Woo‐Keun Seo +7 more
doaj +1 more source

Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update

Current Anesthesiology Reports, 2022
Purpose of Review Multiple guidelines and recommendations have been written to address the perioperative management of antiplatelet and anticoagulant drugs.
M. Moster, D. Bolliger
semanticscholar +1 more source

Smoking may be more harmful to vasospastic angina patients who take antiplatelet agents due to the interaction: Results of Korean prospective multi-center cohort.

PLoS ONE, 2021
BackgroundThe interaction between smoking and the use of antiplatelet agents on the prognosis of vasospastic angina (VA) is rarely investigated.MethodsVA-Korea is a nation-wide multi-center registry with prospective design (n = 1812).
Seong-Sik Cho +15 more
doaj +1 more source

Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review

Open Heart, 2021
Although primarily affecting the respiratory system, COVID-19 causes multiple organ damage. One of its grave consequences is a prothrombotic state that manifests as thrombotic, microthrombotic and thromboembolic events.
K. Matli +5 more
semanticscholar +1 more source

medicine
aspirin
chemistry

antiplatelet
antiplatelet therapy
ticagrelor

stroke
medicine general
prasugrel